Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

240
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
240
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Seizures: Classification01:13

Seizures: Classification

300
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
300
Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
142
Pharmacovigilance01:19

Pharmacovigilance

771
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
771

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hitching a Ride to Overcome Barriers: Nonclinical Safety Considerations for Bioconjugated Oligonucleotides.

International journal of toxicology·2026
Same author

Select Histochemical and Immunohistochemical Methods to Investigate the Cell and Tissue Composition of the Mouse Placenta and Metrial Gland.

Toxicologic pathology·2026
Same author

Toxicologic Pathology Forum Opinion*: In Defense of Scientific Freedom.

Toxicologic pathology·2026
Same author

Toxicologic Pathology Forum: Opinion on Considerations for Determination of Adverse Versus Nonadverse Nerve Fiber Degeneration in Nonclinical Toxicity Studies of Oligonucleotides Delivered Directly Into the Intrathecal Space.

Toxicologic pathology·2026
Same author

5-Methoxy-N,N-Dimethyltryptamine: Functional Safety Pharmacology and Video-EEG Assessment of a Short-Acting Serotonergic Psychedelic in Beagle Canines.

International journal of toxicology·2026
Same author

Scientific and Regulatory Policy Committee Points to Consider*: Sample Selection, Assay Design, Data Generation and Interpretation, and Reporting Practices for Chromogenic Immunohistochemical (IHC) Assays in Nonclinical Drug Development.

Toxicologic pathology·2025

Related Experiment Video

Updated: Jun 3, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.0K

Identifying and Understanding Seizure Liability in Drug Development.

Katie Sokolowski1, Laura Erwin2, Judy Liu3

  • 1Safety Assessment, Denali Therapeutics, South San Francisco, CA, USA.

International Journal of Toxicology
|January 7, 2025
PubMed
Summary
This summary is machine-generated.

Investigating drug-induced seizures in nonclinical species is crucial for drug development. This study details methods to accurately identify and assess seizure risks, ensuring clinical safety.

Keywords:
EEGconvulsionselectroencephalographyneurotoxicitynonclinicalrisk assessmentseizures

More Related Videos

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

8.9K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

32.9K

Related Experiment Videos

Last Updated: Jun 3, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.0K
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

8.9K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

32.9K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Drug Development

Background:

  • Seizures are complex neurological events impacting brain function.
  • Test article (TA)-induced seizures present significant challenges in pharmaceutical research and development.
  • Understanding seizure manifestations and assessment is vital for drug safety evaluation.

Purpose of the Study:

  • To outline methods for investigating test article-related seizure liabilities in nonclinical species.
  • To emphasize the importance of distinguishing seizures from convulsions and understanding seizure types and phases.
  • To guide the alignment of nonclinical seizure findings with clinical relevance for risk assessment.

Main Methods:

  • Utilizing electroencephalography (EEG) for direct seizure confirmation in nonclinical studies.
  • Employing functional observational batteries (FOB) and neurological examinations for clinical endpoint assessment.
  • Analyzing neuropathological findings and biomarkers (CSF, serum) to identify seizure origin, frequency, and severity.

Main Results:

  • EEG is the most direct method for confirming seizures in nonclinical safety testing.
  • Clinical endpoints and neuropathological data provide crucial information on seizure liability.
  • Accurate characterization of seizures is essential for determining clinical implications.

Conclusions:

  • Regulatory bodies consider nonclinical seizure data and risk management strategies effective for clinical risk assessment.
  • Distinguishing seizures from convulsions and understanding seizure nuances are key to evaluating clinical relevance.
  • Comprehensive assessment integrating EEG, clinical endpoints, and neuropathology is vital for drug safety.